Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Effect of Hypoxia, Oscillatory Hypoxia, and Lactate on MDA 231 Cells

ABSTRACT: MDA 231 cells were cultured under hypoxia, normoxia, oscillatory hypoxia, and lactate and sequenced for RNA

ORGANISM(S): Homo sapiens

PROVIDER: GSE261312 | GEO | 2024/03/14

REPOSITORIES: GEO

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
		Other

Items per page:

1 - 1 of 1

Similar Datasets

Expression data from MDA-MB-231 cells exposed to hypoxia and/or paclitaxel or epirubicin

Project description:Hypoxia protects cancer cells from chemotherapeutic drug-induced cell death. We used microarrays to detail the changes in gene expression underlying hypoxia-induced chemoresistance in cancer cells. MDA-MB-231 were exposed to paclitaxel or epirubicin under normoxia or hypoxia for 16hours, then RNA was extracted and analyzed by Affymetrix arrays

2012-07-02 | E-GEOD-39042 | biostudies-arrayexpress

Gene expression in HTR-8/SVneo cells exposed to hypoxia or treated with sodium L-lactate

Project description:Chronical hypoxia is a common occurrence following reduced uteroplacental blood flow resulting from incomplete trophoblast invasion and abnormal vascular remodeling of the spiral arteries in PE. Hypoxia can lead to active glycolysis, which increases the production of lactate, a substrate for histone lactylation. To screen for genes that may be regulated by histone lactylation in PE placentas, we performed RNA-seq in HTR-8/SVneo cells under hypoxia or treated with sodium L-lactate. The results showed that 3578 genes were upregulated in the HTR-8/SVneo cells under hypoxia compared to those under normoxia, and 355 genes were upregulated in HTR-8/SVneo cells treated with sodium L-lactate compared to the control cells. 152 upregulated genes in the HTR-8/SVneo cells under hypoxia and those treated with sodium L-lactate overlapping.

2021-12-13 | GSE190694 | GEO

Hypoxia response by human breast cancer cell MDA-MB-231 sublines

Project description:Two MDA-MB-231 sublines, SCP2 and LM2 (4175), were applied to low oxygen (1%) for 0, 6 and 24 hours, then profiled for RNA expression. Two sublines, each sublines has three conditions: 0h, 6h and 24h for hypoxia treatment. Each condition has two repeats. Total 12 samples

2010-06-16 | E-GEOD-17188 | biostudies-arrayexpress

MDA-MB-231 Breast Cancer Bone Tropic vs Parental Hypoxic Secretome Analysis

Project description:The project profiled the expression patterns in hypoxia induced secretomes between MDA-MB-231 parental and MDA-MB-231 Bone Tropic (BT) breast cancer cell lines which have been previously generated by Massague and colleagues (Kang et al. Cancer Cell 2003).

2017-03-29 | MSV000080797 | MassIVE

MDA-MB-231 Breast Cancer Bone Tropic vs Parental Hypoxic Secretome Analysis

2015-05-28 | PXD000397 | Pride

Analysis of transcriptomes in HUVECs treated with exosomes derived from hypoxia-induced MDA-MB-231

Project description:To study the cancer exosome-induced changes in HUVECs, we characterized the transcriptomes in HUVECs treated with exosomes derived from hypoxia-induced MDA-MB-231. We found the exosomes upregulated the epithelial–mesenchymal transition(EMT)-related and metabolism-related genes in HUVECs.

2021-05-19 | GSE153694 | GEO

Lactate- and hypoxia-induced beta-glucan masking in responding and non-responding Candida albicans clinical isolates

Project description:RNA sequencing was performed on Candida albicans clinical isolates that display normal (isolates: 3560, 3605, 3609, 4108, 4259) or aberrant (isolates: 3534, 3544, 3621, 3636, 4036) beta-glucan masking in response to lactate and hypoxia. Each clinical isolate was grown to exponential phase in GYNB under normoxic conditions and then exposed for 5 h to: (a) 1% lactate; (b) 0% lactate control; (c) hypoxia; or (d) normoxic control. Three independent experiments were performed for each clinical isolate.

2023-09-05 | E-MTAB-10986 | biostudies-arrayexpress

Hypoxic MDA-MB-231 miRNA array

Project description:MiR-544 was inhibited by either a miR-544 antagomir or compound 1 under hypoxic conditions in MDA-MB-231 cells MiRNA microarray was utilized to examine the specificity of 1 for miR-544. 3 MDA-MB-231 samples treated with a miR-544 antagomir or compound 1 were subjected to hypoxia for a period of 5 days. After 5 days, samples were pooled and subjected to miRNA microarray analysis.

2014-12-23 | E-GEOD-64436 | biostudies-arrayexpress

MDA-231-Gem cells and MDA-231 cells

Project description:MDA-231-Gem cells and MDA-231 cells

| PRJNA266805 | ENA

Hypoxic MDA-MB-231 U133 Plus 2.0 array

Project description:MiR-544 was inhibited by either a miR-544 antagomir or compound 1 under hypoxic conditions in MDA-MB-231 cells U133 Plus 2.0 microarray was utilized to examine the specificity of 1 for miR-544. 3 MDA-MB-231 samples treated with a miR-544 antagomir or compound 1 were subjected to hypoxia for a period of 5 days. After 5 days, samples were pooled and subjected to gene level microarray analysis.

2014-12-23 | E-GEOD-64435 | biostudies-arrayexpress

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data